Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Back
Evaluation ViewAttendees 117

Academic and Research Skills

Cardiology

Clinical Research

Critical Care

General Pediatrics

Neonatology
Session Type: Club in Conv Center

Neonatal Hemodynamics Club

Saturday, April 26, 2025
8:30am – 9:50am HST
Location: Convention Center: Kalākaua Ballroom A (Level 4)
CE: 1.5

Disclosure(s):
Martin Kluckow, MBBS FRACP: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Audrey Hebert, MD, FRCPC, MHSc: Mallinckrodt (Terminated, September 12, 2024) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness)

The Neonatal Hemodynamics Club addresses clinically relevant topics in neonatal-perinatal medicine with a special focus on developmental cardiovascular physiology and neonatal hemodynamics. The topic for 2025 will explore the hemodynamic physiology in extreme preterm infants and targeted therapy of Patent Ductus Arteriosus. Our first speaker will review the evidence on early targeted management of PDA and discuss pros and cons of this approach. Our second speaker will appraise the evidence for physiologically targeted therapies in different cardiovascular phenotypes. We will discuss the possible next steps to understand what is optimal management in these high risk hemodynamic states.
There will be time set aside for audience questions and discussion to allow the audience to interact with our expert speakers.

Learning Objectives:

  • Upon completion participants will be able to understand the challenges and importance of cardiovascular physiology and management in extremely preterm infants .
  • Upon completion participants will be able to learn the value of enhanced diagnostic precision with Targeted Neonatal Echocardiography guided care
  • Upon completion participants will be able to incorporate best evidence in optimizing the care of this high-risk population.

Presentations:

  • 8:30am – 8:35am HST
    Introduction: Cardiovascular Risk in ELBW Infants in the Transitional Period

    Speaker: Martin Kluckow, MBBS FRACP – Sydney University

  • 8:35am – 9:05am HST
    Early Screening for Patent Ductus Arteriosus and Targeted Treatment

    Speaker: Samir Gupta, MD, DM, FRCPCH, FRCPI (he/him/his) – Sidra Medicine, Qatar & Durham University, United Kingdom

  • 9:05am – 9:35am HST
    Targeting Cardiovascular Phenotypes in the Care of Extremely Preterm Infants in the Transitional Period

    Speaker: Patrick McNamara, MB BCh MRCPCH MSc – University of Iowa Stead Family Children's Hospital

  • 9:35am – 9:50am HST
    Audience Q&A

    Speaker: Audrey Hebert, MD, FRCPC, MHSc – CHU de Quebec - Universite Laval